Rare diseases
Investigational molecules
Locations
Back to France1 508 clinical trials in Quint-Fonsegrives, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A study to evaluate the safety and effectiveness of nivolumab and imiquimod in adults with vulvar squamous cell carcinoma
FranceA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
FranceA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
FranceOne-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease
FrancePhase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis
FranceStudy evaluating the effect of levetiracetam on recovery in patients with intracerebral haemorrhage
FranceA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
FranceStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
FranceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceComparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
FranceStudy of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
FranceA study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies for both muscle-invasive and non-muscle-invasive cases. Studies also address prostate conditions, from benign hyperplasia to advanced cancer.
Novel approaches combine immunotherapy with targeted treatments to improve patient outcomes.
Comprehensive research into breast cancer treatments, particularly focusing on triple-negative and hormone receptor-positive variants. Studies evaluate new approaches in colon cancer management using circulating tumor DNA analysis.
Investigations combine immunotherapy with traditional treatments for enhanced efficacy.
Research addressing pulmonary conditions and specialized medical needs. Studies include evaluation of treatments for chronic obstructive pulmonary disease and migraine management in emergency settings.
Focus on improving patient quality of life through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
